STOCK TITAN
  1. Home
  2. News
  3. ABT

Abbott Laboratories - ABT STOCK NEWS

Welcome to our dedicated news page for Abbott Laboratories (Ticker: ABT), a resource for investors and traders seeking the latest updates and insights on Abbott Laboratories.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Abbott Laboratories's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Abbott Laboratories's position in the market.

News
Abbott and Damar Hamlin Team Up To Build Heart Health Community With New Heartmates Program
Rhea-AI Summary
Abbott (NYSE:ABT) has announced the launch of the Abbott HeartMates program, a new initiative aimed at creating a supportive community for people impacted by heart conditions. The program will provide emotional support, storytelling, and connection opportunities for participants. Professional football player Damar Hamlin will serve as the program's first ambassador. Heart disease affects over 100 million Americans, and the program aims to empower individuals to achieve their own comeback stories.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.49%
Tags
none
-
News
Abbott and Sherri Shepherd: Millions Not Using Affordable Diabetes Technology
Rhea-AI Summary
Abbott announced 'Countdown at a Crossroads,' an animated installation at the Oculus Center in New York City to raise awareness of diabetes and the benefits of continuous glucose monitoring (CGM) systems. The installation features the faces and stories of people impacted by diabetes, including Sherri Shepherd. Every visit to www.Crossroads.Abbott during National Diabetes Awareness Month triggers a donation to the American Diabetes Association's Health Equity Now program.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.49%
Tags
none
-
News
Abbott and Damar Hamlin Team Up to Build Heart Health Community with New HeartMates Program
Rhea-AI Summary
Abbott (NYSE: ABT) has announced the launch of the Abbott HeartMates program, a new initiative aimed at creating a supportive community for people impacted by heart conditions. The program will provide emotional support, connection with others going through similar journeys, and the opportunity to share stories. Professional football player Damar Hamlin will serve as the program's first ambassador. Heart disease affects over 100 million Americans, and the program seeks to empower individuals to achieve their own comeback stories.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.67%
Tags
none
News
Tackling Student Loans and Saving - Together
Rhea-AI Summary
Abbott introduces a new blueprint to assist companies in supporting their employees in paying off school debt and saving for retirement. The program aims to alleviate stress for young adults with student loans.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.16%
Tags
none
-
News
Ninety-One Percent of Young Adults With Student Loans Say Financial Stress Is Impacting Their Wellness
Rhea-AI Summary
Abbott launches blueprint of award-winning program to help companies tackle student loan debt. New survey shows 91% of young adults with student loans are experiencing financial stress impacting their wellness. Abbott's Freedom 2 Save program offers a solution by helping employees pay off student loans while saving for the future. The blueprint guides employers in implementing a similar benefit. Student loan debt is the third-largest form of consumer debt in the US, with $1.57 trillion owed collectively. 94% of young adults with student debt are interested in an employer-provided 401(k) contribution as they pay off their loans.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.2%
Tags
none
-
News
Ninety-One Percent of Young Adults With Student Loans Say Financial Stress is Impacting Their Wellness -- Abbott Launches Blueprint of Award-Winning Program to Help Companies Tackle This Problem
Rhea-AI Summary
Abbott launches Freedom 2 Save blueprint to help companies create student loan benefit programs. 91% of young adults with student loans report financial stress impacting their wellness. 94% interested in employer-provided 401(k) contribution while paying off loans.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.44%
Tags
none
News
Late-Breaking Data Show Esprit™ BTK Drug-Eluting Resorbable Scaffold Reduces Chronic Limb-Threatening Ischemia Progression Compared to the Standard of Care
Rhea-AI Summary
Abbott announces positive results from the LIFE-BTK clinical trial, demonstrating the effectiveness of its Esprit BTK Everolimus Eluting Resorbable Scaffold System in treating chronic limb-threatening ischemia (CLTI). The trial showed that Esprit BTK reduces disease progression and improves medical outcomes compared to the current standard of care. Abbott plans to submit the device for FDA review.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.31%
Tags
none
-
News
Can Health Tech Be the Most Helpful Technology of All?
Rhea-AI Summary
Abbott is working hard to bring health and technology together to help people understand their health better. They aim to give individuals more control over managing their health by providing data and information. Abbott's technologies, such as continuous glucose monitors and virtual clinics, are already helping people improve their health. They are committed to advancing better health for more people and making health technology the most helpful technology of all.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.31%
Tags
none
-
News
Late-Breaking Data Showcase the Benefits of Abbott's Minimally Invasive Devices for People With Leaky Heart Valves
Rhea-AI Summary
Abbott presents new data at TCT 2023 showing the impact of its minimally invasive heart devices in treating mitral and tricuspid valve disease. The data confirm the safety, effectiveness, and improvements in quality of life when using TriClip for tricuspid regurgitation and MitraClip for mitral regurgitation. The studies highlight significant reductions in regurgitation and improvements in patient outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.31%
Tags
none
News
Sharing the Access Code to Help Open Up Diabetes Care
Rhea-AI Summary
Abbott is working to expand access to its continuous glucose monitoring technology for people with diabetes. The FreeStyle Libre system eliminates routine fingersticks and provides real-time access to glucose numbers. Abbott has already improved the lives of over 5 million people with diabetes, but there is still a large population that could benefit from the technology. Medicare in the US and the French health authorities have expanded coverage for Abbott's technology, and other countries are following suit. Abbott is focused on making its technology accessible and affordable to as many people as possible.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.01%
Tags
none
Stock ABT logo
Abbott Laboratories

NYSE:ABT

ABT Rankings

#51 Ranked by Market Cap
#2392 Ranked by Stock Gains
#1395 Ranked by Dividends

ABT Stock Data

189.50B
1.72B
0.54%
77.02%
0.83%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States
North Chicago

About ABT

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.